Immunome, Inc. (IMNM)
NASDAQ: IMNM · Real-Time Price · USD
11.37
+0.30 (2.71%)
Jul 23, 2025, 3:32 PM - Market open
Immunome Market Cap
Immunome has a market cap or net worth of $989.33 million as of July 23, 2025. Its market cap has increased by 37.14% in one year.
Market Cap
989.33M
Enterprise Value
685.48M
1-Year Change
37.14%
Ranking
Category
Stock Price
$11.37
Market Cap Chart
Since the IPO on October 2, 2020, Immunome's market cap has increased from $111.39M to $989.33M, an increase of 788.16%. That is a compound annual growth rate of 57.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 22, 2025 | 963.23M | 45.31% |
| Dec 31, 2024 | 662.87M | 44.98% |
| Dec 29, 2023 | 457.21M | 1,605.70% |
| Dec 30, 2022 | 26.80M | -82.91% |
| Dec 31, 2021 | 156.82M | 53.68% |
| Dec 31, 2020 | 102.04M | -8.39% |
| Oct 2, 2020 | 111.39M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 684.24B |
| Johnson & Johnson | 395.46B |
| AbbVie | 326.52B |
| Novo Nordisk | 286.26B |
| UnitedHealth Group | 255.94B |
| Novartis AG | 222.44B |
| Abbott Laboratories | 216.47B |
| AstraZeneca | 214.29B |